Navigation Links
Sciedu Press Support the New Open Access Policy of Canadian Institutes of Health Research
Date:11/14/2013

TORONTO, Nov. 14, 2013 /PRNewswire-iReach/ -- A Canadian based company, Sciedu Press (Linkedin) is an open access scholarly journal publisher that deals with all scientific research. Their main expertise lies in the field of education, culture and biological as well as social sciences. Their basic aim is to spread awareness and give scope to all writers who want to publish their research that is based on facts and figures, authenticating any subject and/or topic.

(Photo:  http://photos.prnewswire.com/prnh/20131114/MN16665)

The dedication and passion of Sciedu Press can be validated by the idea that even their name implies their work. Sciedu is a short formed combination of science and education. This shows that they firmly believe in educating the masses scientifically.

They also sponsor as well as support research projects, international networks and corporation in science, education and culture.  

Since its conception in 2000, under the authority of Canadian Institutes of Health and Research Act, Canadian Institutes of Health and Research has been working to improve the health services and products provided to all citizens. Their aim is advance, promote and build up the strength of the Canadian health system.

CIHR is basically an independent health research investment agency that is made up of 13 institutes and is answerable to the Parliament. They provide assistance and support to more than 14,100 trainees and health researchers throughout Canada. They are closely associated with the Minster of Health to ensure the fitness and wellness of all the Canadians.  

The first question that comes to mind is what is open access policy? It is a policy that supports the publication and accessibility of research by international research community, increasing the research result's application in open domain. What this is basically does is that it increases reliability, trustworthiness and a general sense of 'no hiding' or shady research.

Since Canadian Institutes of Health Research is an organization dependent upon public funds, their purpose is to let a huge audience be able to access all research publications. This barrier less approach ensures that public health research improves thereby improving medical conditions across the country. With the help of internet, this task has not only been made easier, it has also been made interactive.

The Open Access Policy commits to freedom of academics for one and all. And this is why Sciedu Press is a huge supporter. They agree with the concept of spreading research publication as widely as possible, so that everyone can have access to it. It would create an effective diffusion of results generated by research.    

Sciedu Press has been working hard in the research publishing community to create awareness and show support of promoting widespread scientific research and education. They believe that nothing is more important that allowing everyone to be on equal footing when it comes to education, the availability and accessibility of research material. For them, the utmost importance is of their user experience and they want to bring scientific research to the hands of the masses.    

 

Media Contact: Evan Ballmer, Sciedu Press, +1 416-479-0028, webtech8899@gmail.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Sciedu Press
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Sciedu Press Supports Open Access Journal Publishing
2. Sciedu Press Launches New Journal for Management and Orgnaization Studies
3. How Sciedu Press Has Taken the Initiative to Sponsor Scholartools.org
4. Nations Best Health Care Organizations for Patient Satisfaction, Core Measures Honored by Press Ganey
5. Compressus Drives Programmable Workflow And Unprecedented Flexibility With Introduction of MEDxConnect™ v4.0
6. Breast Cancer Vaccine Being Developed by Generex Subsidiary Antigen Express to be Featured on Bloomberg Television Today
7. Generex Subsidiary Antigen Express Provides Update on AE37 Cancer Vaccines Clinical & Regulatory Strategy
8. Veracyte Announces Medicare Coverage for Its Afirma® Gene Expression Classifier for Improved Thyroid Nodule Diagnosis
9. Live Press Briefing on Findings of Biomedical Industry CEO Survey
10. Neuralstem President and CEO to Update Ongoing ALS and NSI-189/Major Depressive Disorder Trials at 2012 Biotech Showcase
11. Valkee and University of Oulu Publish the First Clinical Trial on Bright Light Therapy Channeled via ear Canals in Seasonal Depression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... (NASDAQ: VWR), the leading global independent provider of product and ... financial results for the fourth quarter and full year ended ... 4Q16 record quarterly net sales of $1.13 billion, up 1.6% ... 4Q16 EMEA-APAC segment net sales increased 0.4%, ... sales increased 2.5%, or down 0.9% on an organic basis, ...
(Date:2/23/2017)... - The Fight Against Cancer Innovation Trust (FACIT) and ... to report that Fusion Pharmaceuticals Inc. (Fusion) has closed ... Innovation – JJDC, Inc. (JJDC) as the lead investor. ... Partners, and Genesys Capital, as well as founding investor ... ...
(Date:2/23/2017)... ... February 23, 2017 , ... Brain ... to begin marketing the SPEAC® System, the Brain Sentinel® Seizure Monitoring and Alerting ... in healthcare facilities during periods of rest. A lightweight, non-invasive monitor is placed ...
(Date:2/23/2017)... Therapeutics, Inc. (NASDAQ: CAPR), a biotechnology company developing biological therapies ... Marbán, Ph.D, president and chief executive officer, is scheduled to ... Cowen and Company 37th Annual Health Care Conference Tuesday, March ... 29th Annual ROTH Conference Tuesday, ... Dana Point, CA ...
Breaking Biology Technology:
(Date:2/14/2017)... 14, 2017  Wake Forest Baptist Medical Center today ... chief executive officer (CEO). Freischlag joins the medical center ... McConnell , M.D., who last year announced that he ... Center, after leading it since 2008.   ... Wake Forest Baptist,s academic health system, which includes Wake ...
(Date:2/10/2017)... DUBLIN , Feb 10, 2017 ... PharmaBiotech,s new report "Personalized Medicine - Scientific and Commercial ... ... in personalized medicine. Diagnosis is integrated with therapy for selection ... emphasis on early detection and prevention of disease in modern ...
(Date:2/8/2017)... 7, 2017  Aware, Inc. (NASDAQ: AWRE ), ... financial results for its quarter and year ended December 31, ... 2016 was $3.9 million compared to $6.9 million in the ... of 2016 was $0.6 million compared to $2.6 million in ... quarter of 2016 was $0.5 million, or $0.02 per diluted ...
Breaking Biology News(10 mins):